Cargando…

A clinical experience of Indian patients with heart failure with reduced left ventricular ejection fraction using an angiotensin receptor-neprilysin inhibitor [ARNI] on an outpatient basis

The goal of this study is to portray an initial experience with the efficacy, safety, and, acceptance of ARNI in ambulatory cardiology practices in India. The research is a retrospective review of single-centre data who began therapy with ARNI in HFrEF between 2019 and 2020. The analysis included da...

Descripción completa

Detalles Bibliográficos
Autores principales: Jariwala, Pankaj, Punjani, Arshad, Boorugu, Harikishan, Madhawar, Dilip Babu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8065353/
https://www.ncbi.nlm.nih.gov/pubmed/33865520
http://dx.doi.org/10.1016/j.ihj.2021.01.002
_version_ 1783682322065784832
author Jariwala, Pankaj
Punjani, Arshad
Boorugu, Harikishan
Madhawar, Dilip Babu
author_facet Jariwala, Pankaj
Punjani, Arshad
Boorugu, Harikishan
Madhawar, Dilip Babu
author_sort Jariwala, Pankaj
collection PubMed
description The goal of this study is to portray an initial experience with the efficacy, safety, and, acceptance of ARNI in ambulatory cardiology practices in India. The research is a retrospective review of single-centre data who began therapy with ARNI in HFrEF between 2019 and 2020. The analysis included data for 454 symptomatic patients, aged 57 ± 20.8 years in NYHA class II-III. During follow-up, patients experienced significant improvement in HF symptoms determined by using Kansas City Cardiomyopathy Questionnaire (KCCQ) and a considerable reduction in NT-proBNP levels. ARNI is associated with substantial clinical benefit in an outpatient setting in HFrEF.
format Online
Article
Text
id pubmed-8065353
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-80653532021-04-27 A clinical experience of Indian patients with heart failure with reduced left ventricular ejection fraction using an angiotensin receptor-neprilysin inhibitor [ARNI] on an outpatient basis Jariwala, Pankaj Punjani, Arshad Boorugu, Harikishan Madhawar, Dilip Babu Indian Heart J Research Brief The goal of this study is to portray an initial experience with the efficacy, safety, and, acceptance of ARNI in ambulatory cardiology practices in India. The research is a retrospective review of single-centre data who began therapy with ARNI in HFrEF between 2019 and 2020. The analysis included data for 454 symptomatic patients, aged 57 ± 20.8 years in NYHA class II-III. During follow-up, patients experienced significant improvement in HF symptoms determined by using Kansas City Cardiomyopathy Questionnaire (KCCQ) and a considerable reduction in NT-proBNP levels. ARNI is associated with substantial clinical benefit in an outpatient setting in HFrEF. Elsevier 2021 2021-01-06 /pmc/articles/PMC8065353/ /pubmed/33865520 http://dx.doi.org/10.1016/j.ihj.2021.01.002 Text en © 2021 Cardiological Society of India. Published by Elsevier B.V. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research Brief
Jariwala, Pankaj
Punjani, Arshad
Boorugu, Harikishan
Madhawar, Dilip Babu
A clinical experience of Indian patients with heart failure with reduced left ventricular ejection fraction using an angiotensin receptor-neprilysin inhibitor [ARNI] on an outpatient basis
title A clinical experience of Indian patients with heart failure with reduced left ventricular ejection fraction using an angiotensin receptor-neprilysin inhibitor [ARNI] on an outpatient basis
title_full A clinical experience of Indian patients with heart failure with reduced left ventricular ejection fraction using an angiotensin receptor-neprilysin inhibitor [ARNI] on an outpatient basis
title_fullStr A clinical experience of Indian patients with heart failure with reduced left ventricular ejection fraction using an angiotensin receptor-neprilysin inhibitor [ARNI] on an outpatient basis
title_full_unstemmed A clinical experience of Indian patients with heart failure with reduced left ventricular ejection fraction using an angiotensin receptor-neprilysin inhibitor [ARNI] on an outpatient basis
title_short A clinical experience of Indian patients with heart failure with reduced left ventricular ejection fraction using an angiotensin receptor-neprilysin inhibitor [ARNI] on an outpatient basis
title_sort clinical experience of indian patients with heart failure with reduced left ventricular ejection fraction using an angiotensin receptor-neprilysin inhibitor [arni] on an outpatient basis
topic Research Brief
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8065353/
https://www.ncbi.nlm.nih.gov/pubmed/33865520
http://dx.doi.org/10.1016/j.ihj.2021.01.002
work_keys_str_mv AT jariwalapankaj aclinicalexperienceofindianpatientswithheartfailurewithreducedleftventricularejectionfractionusinganangiotensinreceptorneprilysininhibitorarnionanoutpatientbasis
AT punjaniarshad aclinicalexperienceofindianpatientswithheartfailurewithreducedleftventricularejectionfractionusinganangiotensinreceptorneprilysininhibitorarnionanoutpatientbasis
AT booruguharikishan aclinicalexperienceofindianpatientswithheartfailurewithreducedleftventricularejectionfractionusinganangiotensinreceptorneprilysininhibitorarnionanoutpatientbasis
AT madhawardilipbabu aclinicalexperienceofindianpatientswithheartfailurewithreducedleftventricularejectionfractionusinganangiotensinreceptorneprilysininhibitorarnionanoutpatientbasis
AT jariwalapankaj clinicalexperienceofindianpatientswithheartfailurewithreducedleftventricularejectionfractionusinganangiotensinreceptorneprilysininhibitorarnionanoutpatientbasis
AT punjaniarshad clinicalexperienceofindianpatientswithheartfailurewithreducedleftventricularejectionfractionusinganangiotensinreceptorneprilysininhibitorarnionanoutpatientbasis
AT booruguharikishan clinicalexperienceofindianpatientswithheartfailurewithreducedleftventricularejectionfractionusinganangiotensinreceptorneprilysininhibitorarnionanoutpatientbasis
AT madhawardilipbabu clinicalexperienceofindianpatientswithheartfailurewithreducedleftventricularejectionfractionusinganangiotensinreceptorneprilysininhibitorarnionanoutpatientbasis